Additionally, KDM5D inhibited tumor growth in colorectal cancer by demethylating E2F1 and suppressing FKBP4 transcription, thereby suggesting that it could possibly serve in the management of colorectal cancer in males [72]. The gene discussed is E2F1; the disease is colorectal cancer.